nach oben

European Journal of Nutrition

Erschienen in:

01.04.2015 | Reply

Intracellular receptor regulation of adipose metabolism by the isoflavone genistein

verfasst von: Isabella Zanella, Diego Di Lorenzo

Erschienen in: European Journal of Nutrition | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Excerpt

In the last few lines of his letter, Dr. Chirumbolo concludes that the complex action of genistein in the modulation of adipose metabolism and growth is dependent on several factors among which the most relevant are its plasma concentration, its nuclear receptor-mediated signaling and the gender. I would add that the dietary background is itself a factor that may shift the variable effect of genistein on adipose metabolism from negative (inhibitory control) to positive (stimulation), influencing the gut microbiota and intestinal metabolization, absorption and bioavailability. …

Ollberding NJ, Lim U, Wilkens LR, Setiawan VW, Shvetsov YB, Henderson BE, Kolonel LN, Goodman MT (2012) Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study. J Natl Cancer Inst 104:67–76CrossRef

Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS (2003) The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 144:3315–3320CrossRef

Slikker W Jr, Scallet AC, Doerge DR, Ferguson SA (2001) Gender-based differences in rats after chronic dietary exposure to genistein. Int J Toxicol 20:175–179CrossRef

Penza M, Montani C, Romani A, Vignolini P, Pampaloni B, Tanini A, Brandi ML, Alonso-Magdalena P, Nadal A et al (2006) Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147:5740–5751CrossRef

Montani C, Penza M, Jeremic M, Biasiotto G, La Sala G, De Felici M, Ciana P, Maggi A, Di Lorenzo D (2008) Genistein is an efficient estrogen in the whole-body throughout mouse development. Toxicol Sci 103:57–67CrossRef

Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Löwik CW (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278:962–967CrossRef

Ajdžanović V, Medigović I, Zivanović J, Mojić M, Milošević V (2015) Membrane steroid receptor-mediated action of soy isoflavones: tip of the iceberg. J Membr Biol 248:1–6CrossRef

Mahmoud AM, Zhu T, Parray A, Siddique HR, Yang W, Saleem M, Bosland MC (2013) Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor. PLoS One 8:10

Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML (2009) Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr 139:898–904CrossRef

10.

González-Granillo M, Steffensen KR, Granados O, Torres N, Korach-André M, Ortíz V, Aguilar-Salinas C, Jakobsson T, Díaz-Villaseñor A, Loza-Valdes A, Hernandez-Pando R, Gustafsson JÅ, Tovar AR (2012) Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice. Diabetologia 55:2469–2478CrossRef

11.

Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, Frost N, Krikov M, Bhanot S, Barros R, et al (2008) Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS 6:1–16

12.

Park HJ, Della-Fera MA, Hausman DB, Rayalam S, Ambati S, Baile CA (2009) Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem 20:140–148CrossRef

13.

Yepuru M, Eswaraka J, Kearbey JD, Barrett CM, Raghow S, Veverka KA, Miller DD, Dalton JT, Narayanan R (2010) Estrogen receptor-beta-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice. J Biol Chem 285:31292–31303CrossRef

14.

Keller H, Givel F, Perroud M, Wahli W (1995) Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 9:794–804

15.

Suzuki T, Hayashi S, Miki Y, Nakamura Y, Moriya T, Sugawara A, Ishida T, Ohuchi N, Sasano H (2006) Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions. Endocr Relat Cancer 13:233–250CrossRef

16.

Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Andò S (2005) Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells. Clin Cancer Res 11:6139–6147CrossRef

17.

Nuñez SB, Medin JA, Braissant O, Kemp L, Wahli W, Ozato K, Segars JH (1997) Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor. Mol Cell Endocrinol 127:27–40CrossRef

18.

Jeong S, Yoon M (2011) 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression. Acta Pharmacol Sin 32:230–238CrossRef

19.

Wang X, Kilgore MW (2002) Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 194:123–133CrossRef

20.

Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139:4252–4263

21.

Zanella I, Marrazzo E, Biasiotto G, Penza M, Romani A, Vignolini P, Caimi L, Di Lorenzo D (2014) Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet. Eur J Nutr. doi: 10.1007/s00394-014-0786-9

Titel: Intracellular receptor regulation of adipose metabolism by the isoflavone genistein
verfasst von: Isabella Zanella
Diego Di Lorenzo
Publikationsdatum: 01.04.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 3/2015
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-015-0849-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Intracellular receptor regulation of adipose metabolism by the isoflavone genistein

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort

Folate administration decreases oxidative status and blood pressure in postmenopausal women

Pomegranate and green tea extracts protect against ER stress induced by a high-fat diet in skeletal muscle of mice

Adherence to the DASH diet and prevalence of the metabolic syndrome among Iranian women

Effect of acute beer ingestion on the liver: studies in female mice

Independent positive association of plasma β-carotene concentrations with adiponectin among non-diabetic obese subjects

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin